Retraction: Isolation and Characterization of a "phiKMV-Like" Bacteriophage and Its Therapeutic Effect on Mink Hemorrhagic Pneumonia (PLoS ONE (2015) 10:1 (e0116571) DOI: 10.1371/journal.pone.0116571);Isolation and characterization of a "phiKMVlike" bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Cao, Zhenhui ^a   Zhang, Jiancheng ^a   Niu, Yan D ^b   Cui, Naizhong ^c   Ma, Yongsheng ^d   Cao, Fang ^a   Jin, Liji ^a,e   Li, Zhen ^a   Xu, Yongping ^a,e  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b ALBERTA AGRICULTURE AND RURAL DEVELOPMENT   (Canada)

^c Datong University   (China)

^d DALIAN OCEAN UNIVERSITY   (China)

^e BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DNA 16S; GENTAMICIN; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN; POLYMYXIN B; TIMENTIN; SEWAGE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL STRUCTURES; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIOPHAGE PHIKMV; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURST FORMING UNIT; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HEMORRHAGIC PNEUMONIA; HISTOLOGY; HOST RANGE; IN VITRO STUDY; IN VIVO STUDY; MALE; MINK; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; CLASSIFICATION; DRUG ADMINISTRATION ROUTE; GENE VECTOR; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEBULIZER; PHYSIOLOGY; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; SEWAGE; VETERINARY; VIROLOGY; VIRUS GENOME;

MUS; MUSTELA; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA;

ANIMALS; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, BACTERIAL; GENETIC VECTORS; GENOME, VIRAL; MICE; MINK; NEBULIZERS AND VAPORIZERS; PNEUMONIA, BACTERIAL; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEWAGE;

EID: 84921817006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0263042     Document Type: Erratum

References (62)

1. Farid AH, Zillig ML, Finley GG, Smith GC (2012) Prevalence of the Aleutian mink disease virus infection in Nova Scotia, Canada. Prev Vet Med 106: 332-338. doi: 10.1016/j.prevetmed.2012.03.010 PMID: 22497690
2. th international scientific congress in fur animal production, Copenhagen, Denmark. pp 157-164.
3. Bai X, Chai XL, Yan XJ, Gao H, Zhang HL, et al. (2011) Biological characteristics and serotyping of Pseudomonas aeruginosa isolated from the mink. Anim Husb and Vet Med 43: 31-35. (In Chinese)
4. Salomonsen CM (2012) Hemorrhagic pneumonia in mink caused by Pseudomonas aeruginosa: D. Denmark: National Veterinary Institute, Technical University of Denmark. pp 13-14.
5. Hammer AS, Pedersen K, Andersen TH, Jørgensen JC, Dietz HH (2003) Comparison of Pseudomonas aeruginosa isolates from mink by serotyping and pulsed-field gel electrophoresis. Vet Microbiol 94: 237-243. doi: 10.1016/S0378-1135(03)00103-2 PMID: 12814891
6. Wang CA (2007) Breeding and diseases control of fur animals. Beijing, China: Golden Shield Press. (In Chinese)
7. Pedersen K, Hammer AS, Sørensen CM, Heuer OE (2009) Usage of antimicrobials and occurrence of antimicrobial resistance among bacteria from mink. Vet Microbiol 133: 115-122. doi: 10.1016/j.vetmic. 2008.06.005 PMID: 18620819
8. Wlash C (2003) Where will new antibiotics come from? Nat Rev Microbiol 1: 65-70. doi: 10.1038/ nrmicro727 PMID: 15040181
9. Huff WE, Huff GR, Rath NC, Balog JM, Donoghue AM (2005) Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult Sci 84: 655-659. PMID: 15844825
10. Brüssow H, Hendrix RW (2002) Phage genomics: small is beautiful. Cell 108: 13-16. doi: 10.1016/ S0092-8674(01)00637-7 PMID: 11792317
11. Hawkins C, Harper D, Burch D, Anggård E, Soothill J (2010) Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet Microbiol 146: 309-313. doi: 10.1016/j.vetmic.2010.05.014 PMID: 20627620
12. Wright A, Hawkins CH, Anggård EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34: 349-357. doi: 10.1111/j.1749-4486.2009.01973.x PMID: 19673983
13. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) ClustalWand Clustal Xversion 2.0. Bioinformatics 23: 2947-2948. doi: 10.1093/bioinformatics/btm404 PMID: 17846036
14. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599. doi: 10.1093/molbev/msm092 PMID: 17488738
15. Clinical and Laboratory Standards Institute/r (2011) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Orlando, Florida.
16. Chang HC, Chen CR, Lin JW, Shen GH, Chang KM, et al. (2005) Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5. Appl Environ Microbiol 71: 1387-1393. doi: 10.1128/AEM.71.3.1387-1393.2005 PMID: 15746341
17. Ellis EL, Delbruck M (1939) The growth of bacteriophage. J Gen Physiol 22: 365-384. doi: 10.1085/ jgp.22.3.365 PMID: 19873108
18. rd ed. New York, NY: Cold Spring Laboratory Press, Cold Spring Harbor. 2.43-2.58 p.
19. Adriaenssens EM, Ceyssens PJ, Dunon V, Ackermann HW, Van Vaerenbergh J, et al. (2011) Bacteriophages LIMElight and LIMEzero of Pantoea agglomerans, Belonging to the "phikmv-Like Viruses". Appl EnvironMicrobio 77: 3443-3450. doi: 10.1128/AEM.00128-11 PMID: 21421778
20. Pajunen M, Kiljunen S, Skurnik M (2000) Bacteriophage phiYeo3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphage T3 and T7. J Bacteriol 182: 5114-5120. doi: 10. 1128/JB.182.18.5114-5120.2000 PMID: 10960095
21. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, et al. (2008) The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9: 75. doi: 10.1186/1471-2164-9-75 PMID: 18261238
22. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410. doi: 10.1006/jmbi.1990.9999 PMID: 2231712
23. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSIBLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402. doi: 10.1093/nar/25.17.3389 PMID: 9254694
24. Mitra A, Kesarwani AK, Pal D, Nagaraja V (2011) WebGeSTer DB-a transcription terminator database. Nucleic Acids Res 39: D129-135. doi: 10.1093/nar/gkq971 PMID: 20972211
25. Laslett D, Canback B (2004) ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res 32: 11-16. doi: 10.1093/nar/gkh152 PMID: 14704338
26. Lowe TM, Eddy SR (1997) tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res 25: 955-964. doi: 10.1093/nar/25.5.955 PMID: 9023104
27. Sonnhammer ELL, Von Heijne G, Krogh A (1998) A hidden Markov model for predicting transmembrane helices in protein sequences. In: Glasgow J, Littlejohn T, Major F, Lathrop R, Sankoff D and Sensen C, Editors, Proceedings of the Sixth International Conference on Intelligent Systems for Molecular Biology, AAAI Press, Menlo Park, CA. pp 175-182.
28. Käll L, Krogh A, Sonnhammer EL (2004) A combined transmembrane topology and signal peptide prediction method. J Mol Biol 338: 1027-1036. doi: 10.1016/j.jmb.2004.03.016 PMID: 15111065
29. Juretić D, ZoranićL, Zucić D (2002) Basic charge clusters and predictions of membrane protein topology. J Chem Inf Comput Sci 42: 620-632. doi: 10.1021/ci010263s PMID: 12086524
30. Korhonen HT, Cizinauskas S, Jesernics J (2012) Electrophysiological study on CO and CO2 euthanasia in mink (Mustela vison). Ann Anim Sci 12: 597-608.
31. Bursian SJ, Kern J, Remington RE, Link JE, Fitzgerald SD (2013) Dietary exposure of mink (Mustela vison) to fish from the upper Hudson river, New York, USA: effects on reproduction and offspring growth and mortality. Environ Toxicol Chem.
32. Ceyssens PJ, Lavigne R, MattheusW, Chibeu A, Hertveldt K (2006) Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the ØKMV subgroup within the T7 supergroup. J Bacteriol 188: 6924-6931. doi: 10.1128/JB.00831-06 PMID: 16980495
33. Ben HajKhalifa A, Moissenet D, Vu Thien H, Khedher M (2001) Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation. Ann Biol Clin (Paris) 69: 393-403.
34. Lavigne R, Burkal'tseva MV, Robben J, Sykilinda NN, Kurochkina LP, et al. (2003) The genome of bacteriophage ØKMV, a T7-like virus infecting Pseudomonas aeruginosa. Virology 312: 49-59. doi: 10. 1016/S0042-6822(03)00123-5 PMID: 12890620
35. Van Delden C, Iglewski BH (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4: 551-560. doi: 10.3201/eid0404.980405 PMID: 9866731
36. Sadikot RT, Blackwell TS, Christman JW, Prince AS (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171: 1209-1223. doi: 10.1164/rccm.200408-1044SO PMID: 15695491
37. Fujitani S, Sun HY, Yu VL, Weingarten JA (2011) Pneumonia due to Pseudomonas aeruginosa: Part I: Epidemiology, clinical diagnosis, and source. Chest 139: 909-919. doi: 10.1378/chest.10-0166 PMID: 21467058
38. Salomonsen CM, Themudo GE, Jelsbak L, Molin S, Høiby N, et al. (2012) Typing of Pseudomonas aeruginosa from hemorrhagic pneumonia in mink (Neovison vison). Vet Microbiol 163: 103-109.
39. Salomonsen CM, Boye M, Høiby N, Jensen TH, Hammer AS (2013) Comparison of histological lesions in mink with acute hemorrhagic pneumonia associated with Pseudomonas aeruginosa or Escherichia coli Canadian. Can J Vet Res 77:199-204. PMID: 24101796
40. Pantozzi FL, Copes JA, Martino P, Stanchi N (2000) Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from diseased minks. Analecta Vet 1: 32-35.
41. Strateva T, Yordanov D (2009) Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148. doi: 10.1099/jmm.0.009142-0 PMID: 19528173
42. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. doi: 10.1128/CMR.15.2.167-193.2002 PMID: 11932229
43. Theuretzbacher U (2009) Future antibiotics scenarios: is the tide starting to turn? Int J Antimicrob Agents 34: 15-20. doi: 10.1016/j.ijantimicag.2009.02.005 PMID: 19342202
44. Bergh O, Børsheim KY, Bratbak G, Heldal M (1989) High abundance of viruses found in aquatic environments. Nature 340: 467-468. doi: 10.1038/340467a0 PMID: 2755508
45. O 'Flaherty S, Ross RP, Coffey A (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33: 801-819. doi: 10.1111/j.1574-6976.2009.00176.x PMID: 19416364
46. Keary R, McAuliffe O, Ross RP, Hill C, O'Mahony J, et al. (2013) Bacteriophages and their endolysins for control of pathogenic bacteria. In: Méndez-Vilas A. Microbial pathogens and strategies for combating them: science, technology and education, Formatex Research Center, Badajoz, Spain. pp 1028-1040.
47. Harper DR, Enright MC (2011) Bacteriophages for the treatment of Pseudomonas aeruginosa infection. J Appl Microbiol 111: 1-7. doi: 10.1111/j.1365-2672.2011.05003.x PMID: 21410851
48. Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, et al. (2010) Bacteriophages can treat and prevent pseudomonas aeruginosa lung infections. J Infect Dis 201: 1096-1104. doi: 10.1086/651135 PMID: 20196657
49. Mahadevan MS, Nagananda GS, Arijit D, Sourav B, Sandeep S (2009) Isolation of Host-Specific Bacteriophages from Sewage Against Human Pathogens. Asian J Biotechnol 1: 163-170.
50. Lavigne R, Seto D, Mahadevan P, Ackermann HW, Kropinski AM (2008) Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools. Res Microbiology 159: 406-414. doi: 10.1016/j.resmic.2008.03.005 PMID: 18555669
51. Weinbauer MG (2004) Ecology of prokaryotic viruses. FEMS Microbiol Rev 28: 127-181. doi: 10.1016/ j.femsre.2003.08.001 PMID: 15109783
52. Niu YD, Stanford K, Kropinski AM, Ackermann HW, Johnson RP, et al. (2012) Genomic proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7. PLoS One 7. doi: 10.1371/journal.pone.0034585 PMID: 22514640
53. Skurnik M, Pajunen M, Kiljunen S (2007) Biotechnology challenges of phage therapy. Biotech Lett 29: 995-1003. doi: 10.1007/s10529-007-9346-1 PMID: 17364214
54. nd ed. New York, NY: Oxford University Press. pp 725-741.
55. Boraty ski J, Syper D, Weber-Dabrowska B, Łusiak-Szelachowska M, Poźniak G, et al. (2004) Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 9: 253-259. PMID: 15213806
56. Hoe S, Semler DD, Goudie AD, Lynch KH, Matinkhoo S, et al. (2013) Respirable bacteriophages for the treatment of bacterial lung infections. J Aerosol Med Pulm Drug Deliv 26: 317-335. doi: 10.1089/ jamp.2012.1001 PMID: 23597003
57. Bruttin A, Brüssow H (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety of phage therapy. Antimicrob Agents Chemother 49: 2874-2878. doi: 10.1128/AAC.49.7.2874-2878. 2005 PMID: 15980363
58. Morello E, Saussereau E, Maura D, Huerre M, Touqui L, et al. (2011) Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6. doi: 10.1371/journal.pone.0016963 PMID: 21347240
59. Ryan EM, Gorman SP, Donnelly RF, Gilmore BF (2011) Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol 63: 1253-1264. doi: 10.1111/j.2042-7158.2011.01324.x PMID: 21899540
60. Qi AS, Friend J, Yeo L (2008) SAW atomization application on inhaled pulmonary drug delivery. In Proceedings of SPIE Conference on Biomedical Applications of Micro- and Nanoengineering IV and Complex Systems, Melbourne, VIC, United States. pp 1-10.
61. Labiris NR, Dolovich MB (2003) Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 56: 600-612. doi: 10.1046/j.1365-2125.2003.01893.x PMID: 14616419
62. Golshahi L, Seed KD, Dennis JJ, FinlayWH (2008) Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex. J Aerosol Med Pulm Drug Deliv 21: 351-360. doi: 10.1089/jamp.2008.0701 PMID: 18800880